Barrie Nelson Presents Implementing a Metadata Repository Solution at PhUSE Connect

RALEIGH, N.C., June 4, 2018 (Newswire.com) -  Nurocor announced today that Barrie Nelson, the company’s chief standards officer, will join with Pfizer’s Wade Fairbanks at PhUSE Connect US 2018 to present a case study discussing the important points to consider when an organization makes the decision to implement an MDR. Barrie and Wade will be presenting a paper that will be published at the conference and will be available on the Nurocor and PhUSE websites.

Metadata Repository (MDR) solutions are increasingly seen as an essential aspect of a clinical development infrastructure. This presentation will take a practical look at the implementation process and provide practical insight to that process from both a customer and a software vendor perspective.

Wade and Barrie will examine the responsibilities and expectations of the customer and software vendor, project team considerations including who needs to be involved, what skills and experience are required and project sponsorship. Project prerequisites and scope, effective communication strategy and out-of-the-box functionality vs. customer specific customization will be analyzed. They will contrast pre-project expectations with actual experience and highlight those points deemed critical to the success of an MDR Implementation project.

This session will help attendees:

• Learn what it takes to make an MDR implementation successful
• Find out what a customer should be prepared for when implementing an MDR
• Take advice from those that have been through an MDR implementation process

Nurocor’s mission is to bring order to clinical data. The world of clinical data is becoming increasingly complex and Nurocor believes that through disciplined management of data standards and semantics, BioPharma companies can control this complexity and turn it into a business advantage.

Founded by a team combining deep industry expertise with a proven ability to bring technology solutions to market and backed by established venture capital and private equity funds, Nurocor is uniquely positioned to address the standards and metadata challenges facing the BioPharma industry. The Nurocor team has extensive knowledge of the BioPharma business, the R&D data lifecycle and expertise in the practical application of standards development and implementation. It also has an extensive track record of successfully delivering technology solutions to the enterprise.

About Nurocor

Nurocor helps companies like Amgen, Syneos, Novartis, Pfizer and Roche bring order to clinical data to improve the quality of medical research and bring new medicines to patients more quickly. Created by a team combining deep industry expertise with a proven ability to bring technology solutions to market, Nurocor MDR is the industry-leading standards metadata repository enabling the seamless interchange of data between Electronic Data Capture and Clinical Data Management systems and regulatory agencies.

Source: Nurocor